Free Republic 2nd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $66,148
81%  
Woo hoo!! And we're now over 81%!! Thank you all very much!! God bless.

Keyword: 20200326

Brevity: Headers | « Text »
  • 'I was threatened and ostracized': Ex-CDC director Robert Redfield received death threats from scientist colleagues after he publicly said he believed COVID-19 originated in a lab

    06/03/2021 6:46:51 PM PDT · by george76 · 24 replies
    DAILY MAIL ^ | 3 June 2021 | CHRISTOPHER EBERHART
    Ex-CDC director Robert Redfield said during a CNN interview that he believed the coronavirus was made in a lab and escaped. Since then, he received death by fellow scientists, including some he used to call friends, he told Vanity Fair ... 'I expected it from politicians. I didn't expect it from science,' Redfield said.. The coronavirus origin has been at the forefront of debate since last week when Biden ordered intelligence officials to 'redouble' efforts to establish the origin.. It heated up on Tuesday when Dr. Anthony Fauci's emails were published on the Washington Post and Buzzfeed .. The former...
  • FORMER CDC CHIEF SAYS SCIENTISTS THREATENED HIS LIFE FOR SAYING CORONAVIRUS CAME FROM LAB

    06/03/2021 2:43:51 PM PDT · by conservative98 · 43 replies
    Outkick ^ | 6/3/21 | BOBBY BURACK
    Evidence continues to point to the Wuhan Institute of Virology (WIV) as the origin of SARS-CoV-2. Meanwhile, based on the now publicized emails sent to and from Dr. Fauci, it has become evident that there was a strong push to downplay this theory and convince the world the virus evolved naturally. The story grew thicker on Thursday. According to a report from Vanity Fair, last March, leading scientists aggressively tried to silence former Centers for Disease Control and Prevention Director Robert Redfield after stating his belief on CNN that the virus originated from a lab in Wuhan. Following his public...
  • Gilead asks FDA to take back lucrative orphan drug status on possible coronavirus treatment - Remdesivir

    03/26/2020 8:04:17 AM PDT · by SeekAndFind · 3 replies
    Reuters ^ | 03/26/2020 | Manas Mishra, Michael Erman
    Gilead Sciences Inc on Wednesday took the unusual step of asking the U.S. Food and Drug Administration to rescind a controversial orphan drug designation the agency had granted for the biotech company’s potential coronavirus treatment remdesivir just 48 hours earlier. The FDA agreed to the withdrawal, and said it is actively working to speed development of medical products desperately needed to prevent or treat the highly contagious COVID-19 illness caused by the virus. Shares of the California-based company closed down nearly 6% at $69.66. The company was criticized by lawmakers and patient advocates after receiving the orphan designation on Monday...